News By Tag Industry News News By Location Country(s) Industry News
| Three Plenary Keynotes to Take Place at 12th Annual Bio-IT World ExpoDr. Atul Butte, Dr. Andrew Hopkins, and a panel of leading CIOs to deliver Bio-IT World 2013 Keynote Presentations – Complimentary Passes Available Now
Tuesday, April 9, 2013 - Atul Butte, M.D., Ph.D., Division Chief and Associate Professor, Stanford University School of Medicine; Director, Center for Pediatric Bioinformatics, Lucile Packard Children’s Hospital; Co-founder, Personalis and Numedii. Atul Butte, MD, PhD is Chief of the Division of Systems Medicine and Associate Professor of Pediatrics, Medicine, and by courtesy, Computer Science, at Stanford University and Lucile Packard Children’s Hospital. Dr. Butte trained in Computer Science at Brown University, worked as a software engineer at Apple and Microsoft, received his MD at Brown University, trained in Pediatrics and Pediatric Endocrinology at Children’s Hospital Boston, then received his PhD in Health Sciences and Technology from Harvard Medical School and MIT. Dr. Butte is also a founder of Personalis, providing clinical interpretation of whole genome sequences, and NuMedii, finding new uses for drugs. Dr. Butte has authored more than 120 publications and delivered more than 140 invited presentations in personalized and systems medicine, biomedical informatics, and molecular diabetes, including 30 at the National Academies of Science, Institute of Medicine, National Institutes of Health or NIH-related meetings. Dr. Butte’s recent awards include the 2010 Society for Pediatric Research Young Investigator Award, induction into the American College of Medical Informatics in 2009, the 2008 AMIA New Investigator Award, the 2007 Genome Technology “Tomorrow’ Wednesday, April 10, 2013 - Andrew L. Hopkins, D.Phil, FRSC, FSB, Division of Biological Chemistry and Drug Design, College of Life Sciences, University of Dundee. Professor Andrew Hopkins, DPhil, FRSC, FSB is the SULSA Professor at the College of Life Sciences, and Chair of the Department of Medicinal Informatics, University of Dundee, UK. Dr. Hopkins is a leading researcher in the fields of chemoinformatics, chemogenomics and drug discovery, developing novel computational and experimental methods to improve the drug discovery process. He spent several years at Pfizer, collaborating with Chris (“Rule of Five”) Lipinski and others and helping to establish the concept of the “druggable genome.” Since moving to Scotland, the Hopkins Lab has focused on devising new informatics strategies to optimize the design of new drug molecules, incorporating advances in medicinal informatics, network pharmacology, in silico evolutionary optimization, database and machine learning techniques. Dr. Hopkins calls this concept the “chemical beauty” of drugs, measured by a new parameter, the quantitative estimate of drug-likeness (QED). He is the co-founder of a new technology platform company, ex scientia, operating at the IT/healthcare interface by using data analytics and machine learning to enhance drug design and pharmacogenomics. Dr. Hopkins holds an honors degree in chemistry from the University of Manchester and a doctorate in biophysics from Oxford. He was recently elected director of SULSA (Scottish Universities Life Sciences Alliance), a research community of some 11,000 biologists in Scotland. Thursday, April 11, 2013 – In this special plenary roundtable, Bio-IT World invites a select group of CIOs from big pharma, academia and government to discuss the major issues facing today’s biosciences organization and the prospects for future growth and organizational success. The presentation will address the major issues facing today’s biosciences organization and the prospects for future growth and organizational success from the diverse perspectives of big pharma, academia and government. Presenters include: Remy Evard, CIO, Novartis Institutes for BioMedical Research; Martin Leach, Ph.D., Vice President, R&D IT, Biogen Idec; Andrea T. Norris, Director, Center for Information Technology (CIT) and CIO, NIH; Gunaretnam (Guna) Rajagopal, Ph.D., VP & CIO - R&D IT, Research, Bioinformatics & External Innovation, Janssen Pharmaceuticals; Complimentary keynote and exhibit hall passes are available until Friday, March 29, 2013 and can be reserved at http://www.bio- About Bio-IT World Part of the Cambridge Healthtech Institute Media Group, Bio-IT World provides outstanding coverage of cutting-edge trends and technologies that impact the management and analysis of life sciences data, including next-generation sequencing, drug discovery, predictive and systems biology, informatics tools, clinical trials, and personalized medicine. Through a variety of sources including, Bio-ITWorld.com, Weekly Update Newsletter and the Bio-IT World News Bulletins, Bio-IT World is a leading source of news and opinion on technology and strategic innovation in the life sciences, including drug discovery, development. About Cambridge Healthtech Institute Cambridge Healthtech Institute (CHI), founded in 1992, is the industry leader in providing superior quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, and Cambridge Healthtech Media Group. End
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number